Uckelmann, H., S. M. Kim et al. (2020, January) “Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia.” Science. 367(6477):586-590.
Access Scientific References for Our Pipeline Below
-
SNDX-5613 / Menin-MLLr inhibitors
-
Axatilimab / Targeting CSF-1R
-
Entinostat / Immunomodulation
Gandhi L.., M. Johnson, et al. (2017, November). “ENCORE-601: Phase 1b/2 study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer.” Poster and slides presented at the Society for the Immunotherapy of Cancer Annual Meeting, National Harbor, MD.
-
Entinostat / Breast Cancer